Arylvinylpiperazine Amides, a New Class of Potent Inhibitors Targeting QcrB of Mycobacterium tuberculosis

New drugs are needed to control the current tuberculosis (TB) pandemic caused by infection with Mycobacterium tuberculosis. We report here on our work with AX-35, an arylvinylpiperazine amide, and four related analogs, which are potent antitubercular agents in vitro. All five compounds showed good a...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:mBio
Main Authors: Foo, Caroline S., Lupien, Andréanne, Kienle, Maryline, Vocat, Anthony, Benjak, Andrej, Sommer, Raphael, Lamprecht, Dirk A., Steyn, Adrie J. C., Pethe, Kevin, Piton, Jérémie, Altmann, Karl-Heinz, Cole, Stewart T.
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2018
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6178619/
https://ncbi.nlm.nih.gov/pubmed/30301850
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/mBio.01276-18
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki